Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)

International Journal of Molecular Medicine

Volumn 37, Issue 3, 2016, Pages 547-555

  Stefano, George B ^a   Kream, Richard M ^a  

^a MitoGenetics   (United States)

Author keywords

Chloroplasts; Kleptoplasty; Mitochondria; Reactive oxygen species; Stereoselectivity; Translational medicine

Indexed keywords

ANTIBIOTIC AGENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; BEHAVIOR DISORDER; CHLOROPLAST; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; MENTAL DISEASE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ENERGY METABOLISM; METABOLISM; PROCEDURES; TRANSLATIONAL RESEARCH;

CHLOROPLASTS; ENERGY METABOLISM; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84959223912     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2471     Document Type: Article

References (157)

1. Stefano GB and Kream R: Psychiatric disorders involving mitochondrial processes. Psychol Obs 1: 1-6, 2015.
2. Stefano GB, Mantione KJ, Casares FM and Kream RM: Anaerobically functioning mitochondria: Evolutionary perspective on modulation of energy metabolism in Mytilus edulis. Invertebrate Surviv J 12: 22-28, 2015.
3. Snyder C and Stefano GB: Mitochondria and chloroplasts shared in animal and plant tissues: Significance of communication. Med Sci Monit 21: 1507-1511, 2015.
4. Mantione K, Kream RM and Stefano GB: Variations in critical morphine biosynthesis genes and their potential to influence human health. Neuro Endocrinol Lett 31: 11-18, 2010.
5. Esch T and Stefano G: Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Med Sci Monit 8: HY1-HY9, 2002.
6. Takahashi E and Sato M: Anaerobic respiration sustains mitochondrial membrane potential in a prolyl hydroxylase pathway-activated cancer cell line in a hypoxic microenvironment. Am J Physiol Cell Physiol 306: C334-C342, 2014.
7. Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI and Ortiz N: The bio-energetic theory of carcinogenesis. Med Hypotheses 79: 433-439, 2012.
8. Chen Z and Stamler JS: Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc Med 16: 259-265, 2006.
9. Müller M, Mentel M, van Hellemond JJ, Henze K, Woehle C, Gould SB, Yu RY, van der Giezen M, Tielens AG and Martin WF: Biochemistry and evolution of anaerobic energy metabolism in eukaryotes. Microbiol Mol Biol Rev 76: 444-495, 2012.
10. Watt IN, Montgomery MG, Runswick MJ, Leslie AG and Walker JE: Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc Natl Acad Sci USA 107: 16823-16827, 2010.
11. Degli Esposti M: Bioenergetic evolution in proteobacteria and mitochondria. Genome Biol Evol 6: 3238-3251, 2014.
12. Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, et al: Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr Med Chem 21: 2208-2217, 2014.
13. Carvalho C, Machado N, Mota PC, Correia SC, Cardoso S, Santos RX, Santos MS, Oliveira CR and Moreira PI: Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies. J Alzheimers Dis 35: 623-635, 2013.
14. Chong ZZ, Li F and Maiese K: Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75: 207-246, 2005.
15. Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C and Eken J: Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease. Biol Signals Recept 10: 224-253, 2001.
16. Kream RM, Mantione KJ, Casares FM and Stefano GB: Impaired expression of ATP-binDing cassette transporter genes in diabetic ZDF rat blood. Int J Diabetes Res 3: 49-55, 2014.
17. Kream RM, Mantione KJ, Casares FM and Stefano GB: Concerted dysregulation of 5 major classes of blood leukocyte genes in diabetic ZDF rats: A working translational profile of comorbid rheumatoid arthritis progression. Int J Prev Treat 3: 17-25, 2014.
18. Wang F, Guo X, Shen X, Kream RM, Mantione KJ and Stefano GB: Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: A potential etiological linkage. Med Sci Monit Basic Res 20: 118-129, 2014.
19. Wang F, Stefano GB and Kream RM: Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part I). Med Sci Monit 20: 1067-1077, 2014.
20. Wang F, Stefano GB and Kream RM: Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part II). Med Sci Monit 20: 1188-1200, 2014.
21. Panksepp J, Herman B, Conner R, Bishop P and Scott JP: The biology of social attachments: Opiates alleviate separation distress. Biol Psychiatry 13: 607-618, 1978.
22. Pierce RC and Kumaresan V: The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30: 215-238, 2006.
23. Schmauss C and Emrich HM: Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biol Psychiatry 20: 1211-1231, 1985.
24. Stpie A, Stpie M, Wlaze RN, Paradowski M, Banach M and Rysz J: Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: A preliminary report. Med Sci Monit 20: 2683-2688, 2014.
25. Göhring I, Sharoyko VV, Malmgren S, Andersson LE, Spégel P, Nicholls DG and Mulder H: Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal INS-1 832/13 cells. J Biol Chem 289: 3786-3798, 2014.
26. Mantione KJ, Kream RM, Kuzelova H, Ptacek R, Raboch J, Samuel JM and Stefano GB: Comparing bioinformatic gene expression profiling methods: Microarray and RNA-Seq. Med Sci Monit Basic Res 20: 138-142, 2014.
27. Kram KE and Finkel SE: Culture volume and vessel affect long-term survival, mutation frequency, and oxidative stress of Escherichia coli. Appl Environ Microbiol 80: 1732-1738, 2014.
28. Stefano GB and Kream RM: Hypoxia defined as a common culprit/initiation factor in mitochondrial-mediated proinflammatory processes. Med Sci Monit 21: 1478-1484, 2015.
29. Guo R, Li W, Liu B, Li S, Zhang B and Xu Y: Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monit Basic Res 20: 82-92, 2014.
30. Yildirim V, Doganci S, Yesildal F, Kaya E, Ince ME, Ozkan G, Gumusel B, Avcu F and Ozgurtas T: Sodium nitrite provides angiogenic and proliferative effects in vivo and in vitro. Med Sci Monit Basic Res 21: 41-46, 2015.
31. Davila AF and Zamorano P: Mitochondria and the evolutionary roots of cancer. Phys Biol 10: 026008, 2013.
32. Doeller JE, Grieshaber MK and Kraus DW: Chemolithoheterotrophy in a metazoan tissue: Thiosulfate production matches ATP demand in ciliated mussel gills. J Exp Biol 204: 3755-3764, 2001.
33. Doeller JE, Kraus DW, Shick JM and Gnaiger E: Heat flux, oxygen flux, and mitochondrial redox state as a function of oxygen availability and ciliary activity in excised gills of Mytilus edulis. J Exp Zool 265: 1-8, 1993.
34. Tan DX, Manchester LC, Liu X, Rosales-Corral SA, Acuna-Castroviejo D and Reiter RJ: Mitochondria and chloroplasts as the original sites of melatonin synthesis: A hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res 54: 127-138, 2013.
35. Stefano GB, Snyder C and Kream RM: Mitochondria, chloroplasts in animal and plant cells: Significance of conformational matching. Med Sci Monit 21: 2073-2078, 2015.
36. Cruz S, Calado R, Serõdio J and Cartaxana P: Crawling leaves: Photosynthesis in sacoglossan sea slugs. J Exp Bot 64: 3999-4009, 2013.
37. Serõdio J, Cruz S, Cartaxana P and Calado R: Photophysiology of kleptoplasts: Photosynthetic use of light by chloroplasts living in animal cells. Philos Trans R Soc Lond B Biol Sci 369: 20130242, 2014.
38. de Vries J, Christa G and Gould SB: Plastid survival in the cytosol of animal cells. Trends Plant Sci 19: 347-350, 2014.
39. Pennisi E: Microbiology. Modern symbionts inside cells mimic organelle evolution. Science 346: 532-533, 2014.
40. Händeler K, Wägele H, Wahrmund U, Rüdinger M and Knoop V: Slugs' last meals: Molecular identification of sequestered chloroplasts from different algal origins in Sacoglossa (Opisthobranchia, Gastropoda). Mol Ecol Resour 10: 968-978, 2010.
41. Stefano GB: Conformational matching: a possible evolutionary force in the evolvement of signal systems. In: CRC Handbook of Comparative Opioid and Related Neuropeptide Mechanisms. Stefano GB (ed). CRC Press Inc., Boca Raton, pp271-277, 1986.
42. Kerney R, Kim E, Hangarter RP, Heiss AA, Bishop CD and Hall BK: Intracellular invasion of green algae in a salamander host. Proc Natl Acad Sci USA 108: 6497-6502, 2011.
43. Kao WC and Hunte C: The molecular evolution of the Qo motif. Genome Biol Evol 6: 1894-1910, 2014.
44. Renato M, Pateraki I, Boronat A and Azcón-Bieto J: Tomato fruit chromoplasts behave as respiratory bioenergetic organelles during ripening. Plant Physiol 166: 920-933, 2014.
45. Bailey-Serres J and Voesenek LA: FlooDing stress: Acclimations and genetic diversity. Annu Rev Plant Biol 59: 313-339, 2008.
46. Gibbs DJ, Lee SC, Isa NM, Gramuglia S, Fukao T, Bassel GW, Correia CS, Corbineau F, Theodoulou FL, Bailey-Serres J and Holdsworth MJ: Homeostatic response to hypoxia is regulated by the N-end rule pathway in plants. Nature 479: 415-418, 2011.
47. Xu K, Xu X, Fukao T, Canlas P, Maghirang-Rodriguez R, Heuer S, Ismail AM, Bailey-Serres J, Ronald PC and Mackill DJ: Sub1A is an ethylene-response-factor-like gene that confers submergence tolerance to rice. Nature 442: 705-708, 2006.
48. Fukao T, Yeung E and Bailey-Serres J: The submergence tolerance regulator SUB1A mediates crosstalk between submergence and drought tolerance in rice. Plant Cell 23: 412-427, 2011.
49. van Dongen JT and Licausi F: Oxygen sensing and signaling. Annu Rev Plant Biol 66: 345-367, 2015.
50. Gibbs DJ, Conde JV, Berckhan S, Prasad G, Mendiondo GM and Holdsworth MJ: Group VII ethylene response factors coordinate oxygen and nitric oxide signal transduction and stress responses in plants. Plant Physiol 169: 23-31, 2015.
51. Kleine T and Leister D: Emerging functions of mammalian and plant mTERFs. Biochim Biophys Acta 1847: 786-797, 2015.
52. Maier UG, Zauner S, Woehle C, Bolte K, Hempel F, Allen JF and Martin WF: Massively convergent evolution for ribosomal protein gene content in plastid and mitochondrial genomes. Genome Biol Evol 5: 2318-2329, 2013.
53. Coates AR, Halls G and Hu Y: Novel classes of antibiotics or more of the same? Br J Pharmacol 163: 184-194, 2011.
54. Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S, Molina A, Shirihai OS and Collins JJ: Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. Sci Transl Med 5: 192ra85, 2013.
55. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CT, Lobritz MA, Braff D, Schwarz EG, et al: Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA 111: E2100-E2109, 2014.
56. Gray MW, Burger G and Lang BF: The origin and early evolution of mitochondria. Genome Biol 2: reviews1018.1-reviews1018.5, 2001.
57. Zimorski V, Ku C, Martin WF and Gould SB: Endosymbiotic theory for organelle origins. Curr Opin Microbiol 22: 38-48, 2014.
58. Powers JH: Antimicrobial drug development-the past, the present, and the future. Clin Microbiol Infect 10 (Suppl 4): 23-31, 2004.
59. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, et al: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4: 289-294, 1993.
60. Desa D, Nichols MG and Jensen Smith H: The role of complex I in mitochondrial reactive oxygen species formation in cochlear sensory and supporting cells during ototoxic aminoglycoside exposure. Biophys J 108: 611a, 2015.
61. Katsi V, Katsimichas T, Kallistratos MS, Tsekoura D, Makris T, Manolis AJ, Tousoulis D, Stefanadis C and Kallikazaros I: The association of Restless Legs Syndrome with hypertension and cardiovascular disease. Med Sci Monit 20: 654-659, 2014.
62. Stefano GB and Kream RM: Nitric oxide regulation of mitochondrial processes: Commonality in medical disorders. Ann Transplant 20: 402-407, 2015.
63. Jones CN, Miller C, Tenenbaum A, Spremulli LL and Saada A: Antibiotic effects on mitochondrial translation and in patients with mitochondrial translational defects. Mitochondrion 9: 429-437, 2009.
64. Pacheu-Grau D, Gómez-Durán A, Iglesias E, López-Gallardo E, Montoya J and Ruiz-Pesini E: Mitochondrial antibiograms in personalized medicine. Hum Mol Genet 22: 1132-1139, 2013.
65. Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, Jovaisaite V, Frochaux MV, Quiros PM, Deplancke B, et al: Tetracyclines disturb mitochondrial function across eukaryotic models: A call for caution in biomedical research. Cell Rep 10: p1681-1691, 2015.
66. Singh R, Sripada L and Singh R: Side effects of antibiotics during bacterial infection: Mitochondria, the main target in host cell. Mitochondrion 16: 50-54, 2014.
67. Stevens DL: The role of vancomycin in the treatment paradigm. Clin Infect Dis 42 (Suppl 1): S51-S57, 2006.
68. Arimura Y, Yano T, Hirano M, Sakamoto Y, Egashira N and Oishi R: Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. Free Radic Biol Med 52: 1865-1873, 2012.
69. Dieterich C, Puey A, Lin S, Swezey R, Furimsky A, Fairchild D, Mirsalis JC and Ng HH: Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci 107: 258-269, 2009.
70. Sanchez-Alvarez R, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Rubin E, Lisanti MP and Sotgia F: Mitochondrial dysfunction in breast cancer cells prevents tumor growth: UnderstanDing chemoprevention with metformin. Cell Cycle 12: 172-182, 2013.
71. Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP and Sotgia F: Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget 5: 11029-11037, 2014.
72. Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, Clarke RB, Howell SJ, Cappello AR, Martinez Outschoorn UE, et al: Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy. Oncotarget 6: 14005-14025, 2015.
73. Jayaprakash AD, Benson EK, Gone S, Liang R, Shim J, Lambertini L, Toloue MM, Wigler M, Aaronson SA and Sachidanandam R: Stable heteroplasmy at the single-cell level is facilitated by intercellular exchange of mtDNA. Nucleic Acids Res 43: 2177-2187, 2015.
74. Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F and Lisanti MP: Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget 6: 4569-4584, 2015.
75. Leeman MF, Curran S and Murray GI: The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37: 149-166, 2002.
76. Li CH, Cheng YW, Liao PL, Yang YT and Kang JJ: Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion. Toxicol Sci 116: 140-150, 2010.
77. Abouesh A, Stone C and Hobbs WR: Antimicrobial-induced mania (antibiomania): A review of spontaneous reports. J Clin Psychopharmacol 22: 71-81, 2002.
78. Ben-Chetrit E, Rothstein N and Munter G: Ciprofloxacin-induced psychosis. Antimicrob Agents Chemother 57: 4079, 2013.
79. Mulhall JP and Bergmann LS: Ciprofloxacin-induced acute psychosis. Urology 46: 102-103, 1995.
80. Reeves RR: Ciprofloxacin-induced psychosis. Ann Pharmacother 26: 930-931, 1992.
81. Koul S, Bhan-Kotwal S, Jenkins HS and Carmaciu CD: Organic psychosis induced by ofloxacin and metronidazole. Br J Hosp Med (Lond) 70: 236-237, 2009.
82. Dinca EB, Skinner A, Dinca RV and Tudose C: The dangers of gastritis: A case of clarithromycin-associated brief psychotic episode. J Nerv Ment Dis 203: 149-151, 2015.
83. Jiménez-Pulido I, Navarro-Ruiz A, Sendra P, Martínez-Ramírez M, Garcia-Motos C and Montesinos-Ros A: Hallucinations with therapeutic doses of clarithromycin. Int J Clin Pharmacol Ther 40: 20-22, 2002.
84. Korde AS and Maragos WF: Identification of an N-methyl-D-aspartate receptor in isolated nervous system mitochondria. J Biol Chem 287: 35192-35200, 2012.
85. Schmuck G, Schürmann A and Schlüter G: Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother 42: 1831-1836, 1998.
86. Accardi MV, Daniels BA, Brown PM, Fritschy JM, Tyagarajan SK and Bowie D: Mitochondrial reactive oxygen species regulate the strength of inhibitory GABA-mediated synaptic transmission. Nat Commun 5: 3168, 2014.
87. Kawakami J, Yamamoto K, Asanuma A, Yanagisawa K, Sawada Y and Iga T: Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: Correlation with convulsive potency in vivo. Toxicol Appl Pharmacol 145: 246-254, 1997.
88. Zhang HYMB, McPherson BC, Liu H, Baman TS, Rock P and Yao Z: H(2)O(2) opens mitochondrial K(ATP) channels and inhibits GABA receptors via protein kinase C-epsilon in cardiomyocytes. Am J Physiol Heart Circ Physiol 282: H1395-H1403, 2002.
89. Grill MF and Maganti RK: Neurotoxic effects associated with antibiotic use: Management considerations. Br J Clin Pharmacol 72: 381-393, 2011.
90. Stuhec M: Trimethoprim-sulfamethoxazole-related hallucinations. Gen Hosp Psychiatry 36: 230.e237-e238, 2014.
91. Weis S, Karagülle D, Kornhuber J and Bayerlein K: Cotrimoxazole-induced psychosis: A case report and review of literature. Pharmacopsychiatry 39: 236-237, 2006.
92. Lee KY, Huang CH, Tang HJ, Yang CJ, Ko WC, Chen YH, Lee YC and Hung CC: Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: A multicentre, retrospective study. J Antimicrob Chemother 67: 2749-2754, 2012.
93. Quandt-Herrera P, Suarez-Jesus J and Yelmo-Cruz S: Antibiomania: Secondary mania associated with ceftazidime. J Clin Psychopharmacol 35: 619-621, 2015.
94. Landais A, Marty N, Bessis D, Pages M and Blard JM: Hoigne syndrome following an intravenous injection of ceftriaxone: A case report. Rev Med Interne 35: 199-201, 2014 (In French).
95. Stefano GB, Kim C, Mantione K, Casares F and Kream RM: Targeting mitochondrial biogenesis for promoting health. Med Sci Monit 18: SC1-SC3, 2012.
96. Michel TM, Pülschen D and Thome J: The role of oxidative stress in depressive disorders. Curr Pharm Des 18: 5890-5899, 2012.
97. Regenold WT, Pratt M, Nekkalapu S, Shapiro PS, Kristian T and Fiskum G: Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: Implications for brain energy metabolism and neurotrophic signaling. J Psychiatr Res 46: 95-104, 2012.
98. Tobe EH: Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat 9: 567-573, 2013.
99. Hovatta I, Juhila J and Donner J: Oxidative stress in anxiety and comorbid disorders. Neurosci Res 68: 261-275, 2010.
100. Andreazza AC: Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders. Mol Biosyst 8: 2503-2512, 2012.
101. Gigante AD, Andreazza AC, Lafer B, Yatham LN, Beasley CL and Young LT: Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia. Neurosci Lett 505: 47-51, 2011.
102. Rossignol DA and Frye RE: A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17: 389-401, 2012.
103. Mehta SL, Kumari S, Mendelev N and Li PA: Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia. BMC Neurosci 13: 79, 2012.
104. Badjatia N, Seres D, Carpenter A, Schmidt JM, Lee K, Mayer SA, Claassen J, Connolly ES and Elkind MS: Free fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 43: 691-696, 2012.
105. Chen G, Jing CH, Liu PP, Ruan D and Wang L: Induction of autophagic cell death in the rat brain caused by iron. Am J Med Sci 345: 369-374, 2013.
106. McCracken E, Valeriani V, Simpson C, Jover T, McCulloch J and Dewar D: The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab 20: 1529-1536, 2000.
107. Cui J, Holmes EH, Greene TG and Liu PK: Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 14: 955-967, 2000.
108. Panov A, Dikalov S, Shalbuyeva N, Hemendinger R, Greenamyre JT and Rosenfeld J: Species-and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice. Am J Physiol Cell Physiol 292: C708-C718, 2007.
109. Hansson MJ, Månsson R, Morota S, Uchino H, Kallur T, Sumi T, Ishii N, Shimazu M, Keep MF, Jegorov A and Elmér E: Calcium-induced generation of reactive oxygen species in brain mitochondria is mediated by permeability transition. Free Radic Biol Med 45: 284-294, 2008.
110. Opii WO, Nukala VN, Sultana R, Pandya JD, Day KM, Merchant ML, Klein JB, Sullivan PG and Butterfield DA: Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J Neurotrauma 24: 772-789, 2007.
111. Lemasters JJ, Theruvath TP, Zhong Z and Nieminen AL: Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395-1401, 2009.
112. Rasola A, Sciacovelli M, Pantic B and Bernardi P: Signal transduction to the permeability transition pore. FEBS Lett 584: 1989-1996, 2010.
113. Esch T, Stefano GB, Fricchione GL and Benson H: The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett 23: 199-208, 2002.
114. Halliwell B: Oxidative stress and neurodegeneration: Where are we now? J Neurochem 97: 1634-1658, 2006.
115. Tsaluchidu S, Cocchi M, Tonello L and Puri BK: Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8 (Suppl 1): S5, 2008.
116. Masood A, Nadeem A, Mustafa SJ and O'Donnell JM: Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther 326: 369-379, 2008.
117. Arranz MJ and de Leon J: Pharmacogenetics and pharmacogenomics of schizophrenia: A review of last decade of research. Mol Psychiatry 12: 707-747, 2007.
118. Bouayed J, Rammal H, Younos C and Soulimani R: Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol 564: 146-149, 2007.
119. Bouayed J, Rammal H and Soulimani R: Oxidative stress and anxiety: Relationship and cellular pathways. Oxid Med Cell Longev 2: 63-67, 2009.
120. Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E and Catena Dell'Osso M: Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci 16: 270-275, 2012.
121. Ng F, Berk M, Dean O and Bush AI: Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications. Int J Neuropsychopharmacol 11: 851-876, 2008.
122. Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, Belmonte-de-Abreu PS, Berk M and Kapczinski F: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32: 1677-1681, 2008.
123. Wass CE and Andreazza A: The Redox Brain and Nitric Oxide: Implications for Psychiatric Illness. J Pharmacol Clin Toxicol 1: 1008-1009, 2013.
124. Gubert C, Stertz L, Pfaffenseller B, Panizzutti BS, Rezin GT, Massuda R, Streck EL, Gama CS, Kapczinski F and Kunz M: Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res 47: 1396-1402, 2013.
125. Emiliani FE, Sedlak TW and Sawa A: Oxidative stress and schizophrenia: recent breakthroughs from an old story. 27: 185-190, 2014.
126. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, Kapczinski F, Young LT and Yatham LN: Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111: 135-144, 2008.
127. Scola G, Kim HK, Young LT and Andreazza AC: A fresh look at complex I in microarray data: Clues to understanDing disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry 73: e4-e5, 2013.
128. Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, de Vente J, Prickaerts J, Blokland A and Koenig G: Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 47: 1081-1092, 2004.
129. Werner C, Raivich G, Cowen M, Strekalova T, Sillaber I, Buters JT, Spanagel R and Hofmann F: Importance of NO/cGMP signalling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol. Eur J Neurosci 20: 3498-3506, 2004.
130. Wang X, Pinto-Duarte A, Sejnowski TJ and Behrens MM: How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia. Antioxid Redox Signal 18: 1444-1462, 2013.
131. Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J and Chauhan A: Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry 3: e299, 2013.
132. Ptacek R, Stefano GB, Weissenberger S, et al: ADHD and eating disorders: risks and co-Morbidities. J Neuropsychiatric Dis Treat (In press).
133. Ming X, Brimacombe M, Malek JH, Jani N and Wagner GC: Autism spectrum disorders and identified toxic land fills: Co-occurrence across States. Environ Health Insights 2: 55-59, 2008.
134. Frye RE, Delatorre R, Taylor H, Slattery J, Melnyk S, Chowdhury N and James SJ: Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl Psychiatry 3: e273, 2013.
135. Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE and James SJ: Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2: e134, 2012.
136. Kulak A, Steullet P, Cabungcal JH, Werge T, Ingason A, Cuenod M and Do KQ: Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: Insights from animal models. Antioxid Redox Signal 18: 1428-1443, 2013.
137. Kream RM and Stefano GB: De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit 12: RA207-RA219, 2006.
138. Kream RM, Sheehan M, Cadet P, Mantione KJ, Zhu W, Casares F and Stefano GB: Persistence of evolutionary memory: Primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit 13: SC5-SC6, 2007.
139. Stefano GB, Mantione KJ, Capellan L, Casares FM, Challenger S, Ramin R, Samuel JM, Snyder C and Kream RM: Morphine stimulates nitric oxide release in human mitochondria. J Bioenerg Biomembr 47: 409-417, 2015.
140. Kream RM, Stefano GB and Rtacek R: Psychiatric implications of endogenous morphine: up-to-date review. Folia Biol (Praha) 56: 231-241, 2010.
141. Kream RM, Mantione KJ, Sheehan M and Stefano GB: Morphine's chemical messenger status in animals. Activitas Nerv Super Rediviva 51: 153-161, 2009.
142. Mantione KJ, Cadet P, Zhu W, Kream RM, Sheehan M, Fricchione GL, Goumon Y, Esch T and Stefano GB: Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: Autocrine/paracrine feedback inhibition. Addict Biol 13: 118-123, 2008.
143. Stefano GB, Cadet P, Kream RM and Zhu W: The presence of endogenous morphine signaling in animals. Neurochem Res 33: 1933-1939, 2008.
144. Stefano GB, Ptacek R, Kuzelova H and Kream RM: Endogenous morphine: Up-to-date review 2011. Folia Biologica. J Cell Mol Biol 58: 49-56, 2012.
145. Stefano GB and Scharrer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 4: 57-67, 1994.
146. Stefano GB: The evolvement of signal systems: Conformational matching a determining force stabilizing families of signal molecules. Comp Biochem Physiol C 90: 287-294, 1988.
147. Stefano GB: Stereospecificity as a determining force stabilizing families of signal molecules within the context of evolution. In: Comparative Aspects of Neuropeptide Function. Stefano GB and Florey E (eds). University of Manchester Press, Manchester, pp14-28, 1991.
148. Otten AB and Smeets HJ: Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing. Hum Reprod Update 21: 671-689, 2015.
149. Hedges SB, Chen H, Kumar S, Wang DY, Thompson AS and Watanabe H: A genomic timescale for the origin of eukaryotes. BMC Evol Biol 1: 4, 2001.
150. Xavier JM, Rodrigues CM and Solá S: Mitochondria: Major Regulators of Neural Development. Neuroscientist: May 6, 2015 (Epub ahead of print).
151. Dinan TG, Stilling RM, Stanton C and Cryan JF: Collective unconscious: How gut microbes shape human behavior. J Psychiatr Res 63: 1-9, 2015.
152. Wood JP: Communication between the minibrain in gut and enteric immune system. News Physiol Sci (NIPS) 6: 64-69, 1991.
153. Snyder C, Kream RM, Ptacek R and Stefano GB: Mitochondria, microbiome and their potential psychiatric modulation. Autism Open Access (In press).
154. Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, et al: Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 11: 1147-1157, 2013.
155. Guinane CM and Cotter PD: Role of the gut microbiota in health and chronic gastrointestinal disease: UnderstanDing a hidden metabolic organ. Therap Adv Gastroenterol 6: 295-308, 2013.
156. Peterson CT, Sharma V, Elmén L and Peterson SN: Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol 179: 363-377, 2015.
157. Stefano GB, Bilfinger TV and Fricchione GL: The immune-neuro-link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 42: 475-488, 1994.